Drug Price Regulation, B.C. Reg. 344/2012
Section 11
Prices for other drugs
Cite as Drug Price Regulation, B.C. Reg. 344/2012, s. 11 · last amended March 1, 2026 · read from BC Laws on November 17, 2026
The text
(1) This section applies to drugs other than non-reference drugs and high cost drugs.
(2) The maximum amount the minister may pay for a drug that is not subject to the LCA program is the sum of the manufacturer's list price for the drug and 8% of that price.
(3) The maximum amount the minister may pay for a drug that is subject to the LCA program and is in an LCA category having no provisional drugs is the lesser of
(a) the sum of the maximum accepted list price for the LCA category to which the drug belongs and 8% of that price, and
(b) the sum of the manufacturer's list price for the drug and 8% of that price.
(4) The maximum amount the minister may pay for a drug that is subject to the LCA program and is in an LCA category having one or more provisional drugs is the sum of the manufacturer's list price for the highest-priced provisional drug and
(a) 8% of that price if the provisional drug is not a high cost drug, or
(b) 5% of that price if the provisional drug is a high cost drug.
(5) Despite subsections (2) to (4) of this section, if an agreement under section 20 (2) [price regulation] of the Act includes a term respecting the price of a drug, the maximum amount the minister may pay for the drug is the agreed price.
Read the Drug Price Regulation on BC Laws ↗
Made under Pharmaceutical Services Act, SBC 2012, c. 22.